Sensus Healthcare, Inc. Financing Receivable Nonaccrual To Outstanding Percent
Sensus Healthcare, Inc. (SRTS) had Financing Receivable Nonaccrual To Outstanding Percent of 80.00% as of 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Notes
srt:FinancingReceivableNonaccrualToOutstandingPercent · last filed 2022-11-10
- 2022-09-30: Financing Receivable Nonaccrual To Outstanding Percent 80.00%.
- 2021-12-31: Financing Receivable Nonaccrual To Outstanding Percent 51.00%.
| Period end | Financing Receivable Nonaccrual To Outstanding Percent |
|---|---|
| 2022-09-30 | 80.00% 10-Q · filed 2022-11-10 |
| 2021-12-31 | 51.00% 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B |